ilShinBioBase Co

ilShinBioBase Co Financing Cash Flow

The Net Financing Cash Flow of ilShinBioBase Co (068330.KQ) as of Nov 11, 2026 is -308.53 M KRW. In the previous year, Net Financing Cash Flow was -300.06 M KRW — a change of 2.82% (lower).

Financing Cash Flow

-308.53 MKRW

YoY

2.82%

Last updated:

Net Financing Cash Flow of ilShinBioBase Co is 2021 -308.53 M KRW. Net Financing Cash Flow of ilShinBioBase Co was 2020 -300.06 M KRW. It decreases by 2.82% lower compared to the previous year.

The ilShinBioBase Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
-1.50 B KRW
Jan 1, 2015
-1.43 B KRW
Jan 1, 2016
6.40 B KRW
Jan 1, 2017
-2.64 B KRW
Jan 1, 2018
-2.64 B KRW
Jan 1, 2019
-214.33 M KRW
Jan 1, 2020
-300.06 M KRW
Jan 1, 2021
-308.53 M KRW
The ilShinBioBase Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
-308.53 MKRW+2.82%
-300.06 MKRW+40.00%
-214.33 MKRW-91.87%
-2.64 BKRW0.00%
-2.64 BKRW-141.24%
6.40 BKRW-546.47%
-1.43 BKRW-4.49%
-1.50 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Net Financing Cash Flow of ilShinBioBase Co is -308.53 M KRW in 2021.

Net Financing Cash Flow of ilShinBioBase Co changed from -300.06 M KRW to -308.53 M KRW, representing a 2.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's ilShinBioBase Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co